Exploring potential anti-gastric cancer mechanisms of Rhizoma Paridis through integrated computational and experimental analyses
Phytomedicine · 2026-10 · 160 · 158588
DOI: 10.1016/j.phymed.2026.158588 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2026-10. Verfasst von Yinfeng Yang und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Informatics Engineering, Anhui University of Chinese Medicine, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Drugs, Chinese Herbal, Antineoplastic Agents, Phytogenic. Die Arbeit nennt 54 Literaturangaben. Gefördert von: China National Funds for Distinguished Young Scientists.
Abstract (Originalsprache)
BACKGROUND: Gastric cancer (GC) remains a leading cause of cancer-related mortality worldwide, especially in advanced stages with limited treatment efficacy. Rhizoma Paridis (RPS), a traditional Chinese medicinal herb, has shown promising antitumor activity, yet its potential anti-GC mechanisms have not been systematically investigated. METHODS: An integrated computational and experimental framework was established to explore the anti-GC activity and potential mechanisms of RPS. First, the active compounds of RPS and their corresponding targets were identified using UPLC, LC-MS analysis and machine learning (Ml)-driven data mining. Then, the key target genes were determined by the gradient boosting algorithms and their associations with GC were investigated by the deconvolution algorithms, unsupervised clustering and dimensionality reduction methods. Further, the potential compound-target interactions and the mechanism of RPS for treating GC were supported by the molecular docking, Molecular dynamics (MD) simulations, in vivo and in vitro experiments. RESULTS: A total of 118 phytochemicals were identified from RPS, from which 40 candidate bioactive compounds and six hub genes, i.e., BAX, BCL2, VEGFA, KDR, CASP3 and CTNNB1 were prioritized. Functional enrichment analyses suggested that these targets were mainly associated with apoptosis, angiogenesis and Wnt/β-catenin-related signaling pathways. Transcriptomic, prognostic, immune infiltration and single-cell analyses further supported their relevance in GC. Docking and MD simulations indicated favorable binding stability between representative compounds and the key targets. Experimental studies demonstrated that RPS inhibited GC cell proliferation and tumor growth, accompanied by apoptosis-related and angiogenesis-associated molecular changes. CONCLUSION: RPS exhibits significant anti-GC activity and may exert its effects through the coordinated regulation of apoptosis-, angiogenesis- and Wnt/β-catenin-associated pathways. This study provides a systems-level framework integrating computational analyses with biological validation to investigate the pharmacological effects of complex herbal medicines and offers mechanistic insights into the anti-GC potential of RPS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medical Informatics Engineering, Anhui University of Chinese Medicine, Hefei, Anhui, China.
- School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, Anhui, China.
- Global Biometrics and Data Sciences, Bristol Myers Squibb, Lawrenceville, NJ, USA.
- State Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Jiangsu Kanion Pharmaceutical Co. Ltd, Lianyungang, Jiangsu, China.
- Department of Urology, 901st Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Hefei, China.
- Key Laboratory of Industrial Ecology and Environmental Engineering (MOE), Department of Materials Sciences and Chemical Engineering, Dalian University of Technology, Dalian, Liaoning, China.
Förderung
- China National Funds for Distinguished Young Scientists
Zitieren
APA
Yang, Y., Cheng, Z., Yang, J., Yang, P., Gao, H., Yan, B., Wang, X., Zhou, X., Chen, S., Wu, Z., Sheng, H., Dong, Z., Li, Y., Hong, X., Song, H., & Wang, J. (2026). Exploring potential anti-gastric cancer mechanisms of Rhizoma Paridis through integrated computational and experimental analyses. Phytomedicine, 160, 158588. https://doi.org/10.1016/j.phymed.2026.158588
Vancouver
Yang Y, Cheng Z, Yang J, Yang P, Gao H, Yan B, et al. Exploring potential anti-gastric cancer mechanisms of Rhizoma Paridis through integrated computational and experimental analyses. Phytomedicine. 2026;160:158588. doi:10.1016/j.phymed.2026.158588
BibTeX
@article{Yang2026,
author = {Yang, Yinfeng and Cheng, Zhen and Yang, Jianhua and Yang, Peizheng and Gao, Hang and Yan, Biaobiao and Wang, Xiangyu and Zhou, Xuemei and Chen, Shengxi and Wu, Ziyin and Sheng, Haiyang and Dong, Zhiqiang and Li, Yan and Hong, Xinghui and Song, Hang and Wang, Jinghui},
title = {Exploring potential anti-gastric cancer mechanisms of Rhizoma Paridis through integrated computational and experimental analyses},
journal = {Phytomedicine},
year = {2026},
volume = {160},
pages = {158588},
doi = {10.1016/j.phymed.2026.158588}
}
EUVIMED